Skip to content

Drug interactions

Netupitant-palonosetron + Norgestrel

Severity: Minor

Netupitant-palonosetron and Norgestrel: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Netupitant inhibits CYP3A4, which participates in progestin metabolism, so norgestrel exposure may rise somewhat. The increase is expected to be modest and is unlikely to reduce contraceptive efficacy, though progestogenic adverse effects may be more frequent.

What this interaction means in plain words

Netupitant-palonosetron and Norgestrel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Netupitant-palonosetron belongs to Gastrointestinal Tract; Norgestrel belongs to Endocrine.

Evidence level: Low

Why it happens

Netupitant inhibits CYP3A4, reducing norgestrel clearance.

What to do

No dose change is needed; advise patients to report unusual progestogenic adverse effects.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Netupitant-palonosetron and Norgestrel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Netupitant-palonosetron with Norgestrel?

MediHelp rates the interaction as minor. Netupitant-palonosetron and Norgestrel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Netupitant inhibits CYP3A4, which participates in progestin metabolism, so norgestrel exposure may rise somewhat. The increase is expected to be modest and is unlikely to reduce contraceptive efficacy, though progestogenic adverse effects may be more frequent.

How serious is the interaction between Netupitant-palonosetron and Norgestrel?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed; advise patients to report unusual progestogenic adverse effects.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in